 | • レポートコード：MRC2-11QY01144 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、150ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は口唇ヘルペス治療薬のグローバル市場について調査・分析したレポートです。種類別（バラシクロビル、アシクロビル、ファムシクロビル、ドコサノール、その他）市場規模、用途別（外用、経口、注射）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別口唇ヘルペス治療薬の競争状況、市場シェア ・世界の口唇ヘルペス治療薬市場：種類別市場規模 2015年-2020年（バラシクロビル、アシクロビル、ファムシクロビル、ドコサノール、その他） ・世界の口唇ヘルペス治療薬市場：種類別市場規模予測 2021年-2026年（バラシクロビル、アシクロビル、ファムシクロビル、ドコサノール、その他） ・世界の口唇ヘルペス治療薬市場：用途別市場規模 2015年-2020年（外用、経口、注射） ・世界の口唇ヘルペス治療薬市場：用途別市場規模予測 2021年-2026年（外用、経口、注射） ・北米の口唇ヘルペス治療薬市場分析：米国、カナダ ・ヨーロッパの口唇ヘルペス治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの口唇ヘルペス治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の口唇ヘルペス治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの口唇ヘルペス治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GSK、Novartis、Teva、Mylan、Cadila、Apotex、Daewoong Pharmaceutical、Livzon、Luoxin、Med shine、Bayer (Campho Phenique)、Blistex、Kelun Group、Hikma、Haiwang、Carmex、Cipher ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Herpes Labialis Drugs Market
The global Herpes Labialis Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Herpes Labialis Drugs Scope and Market Size
Herpes Labialis Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Herpes Labialis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Herpes Labialis Drugs market is segmented into
Valacyclovir
Aciclovir
Famciclovir
Docosanol
Other
Segment by Application, the Herpes Labialis Drugs market is segmented into
External Use
Oral
Injection
Regional and Country-level Analysis
The Herpes Labialis Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Herpes Labialis Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Herpes Labialis Drugs Market Share Analysis
Herpes Labialis Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Herpes Labialis Drugs business, the date to enter into the Herpes Labialis Drugs market, Herpes Labialis Drugs product introduction, recent developments, etc.
The major vendors covered:
GSK
Novartis
Teva
Mylan
Cadila
Apotex
Daewoong Pharmaceutical
Livzon
Luoxin
Med shine
Bayer (Campho Phenique)
Blistex
Kelun Group
Hikma
Haiwang
Carmex
Cipher
1 Study Coverage
1.1 Herpes Labialis Drugs Product Introduction
1.2 Market Segments
1.3 Key Herpes Labialis Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Herpes Labialis Drugs Market Size Growth Rate by Type
1.4.2 Valacyclovir
1.4.3 Aciclovir
1.4.4 Famciclovir
1.4.5 Docosanol
1.4.6 Other
1.5 Market by Application
1.5.1 Global Herpes Labialis Drugs Market Size Growth Rate by Application
1.5.2 External Use
1.5.3 Oral
1.5.4 Injection
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Herpes Labialis Drugs Market Size, Estimates and Forecasts
2.1.1 Global Herpes Labialis Drugs Revenue 2015-2026
2.1.2 Global Herpes Labialis Drugs Sales 2015-2026
2.2 Global Herpes Labialis Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Herpes Labialis Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Herpes Labialis Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Herpes Labialis Drugs Competitor Landscape by Players
3.1 Herpes Labialis Drugs Sales by Manufacturers
3.1.1 Herpes Labialis Drugs Sales by Manufacturers (2015-2020)
3.1.2 Herpes Labialis Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Herpes Labialis Drugs Revenue by Manufacturers
3.2.1 Herpes Labialis Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Herpes Labialis Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Herpes Labialis Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Herpes Labialis Drugs Revenue in 2019
3.2.5 Global Herpes Labialis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Herpes Labialis Drugs Price by Manufacturers
3.4 Herpes Labialis Drugs Manufacturing Base Distribution, Product Types
3.4.1 Herpes Labialis Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Herpes Labialis Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Herpes Labialis Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Herpes Labialis Drugs Market Size by Type (2015-2020)
4.1.1 Global Herpes Labialis Drugs Sales by Type (2015-2020)
4.1.2 Global Herpes Labialis Drugs Revenue by Type (2015-2020)
4.1.3 Herpes Labialis Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Herpes Labialis Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Herpes Labialis Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Herpes Labialis Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Herpes Labialis Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Herpes Labialis Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Herpes Labialis Drugs Market Size by Application (2015-2020)
5.1.1 Global Herpes Labialis Drugs Sales by Application (2015-2020)
5.1.2 Global Herpes Labialis Drugs Revenue by Application (2015-2020)
5.1.3 Herpes Labialis Drugs Price by Application (2015-2020)
5.2 Herpes Labialis Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Herpes Labialis Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Herpes Labialis Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Herpes Labialis Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Herpes Labialis Drugs by Country
6.1.1 North America Herpes Labialis Drugs Sales by Country
6.1.2 North America Herpes Labialis Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Herpes Labialis Drugs Market Facts & Figures by Type
6.3 North America Herpes Labialis Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Herpes Labialis Drugs by Country
7.1.1 Europe Herpes Labialis Drugs Sales by Country
7.1.2 Europe Herpes Labialis Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Herpes Labialis Drugs Market Facts & Figures by Type
7.3 Europe Herpes Labialis Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Herpes Labialis Drugs by Region
8.1.1 Asia Pacific Herpes Labialis Drugs Sales by Region
8.1.2 Asia Pacific Herpes Labialis Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Herpes Labialis Drugs Market Facts & Figures by Type
8.3 Asia Pacific Herpes Labialis Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Herpes Labialis Drugs by Country
9.1.1 Latin America Herpes Labialis Drugs Sales by Country
9.1.2 Latin America Herpes Labialis Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Herpes Labialis Drugs Market Facts & Figures by Type
9.3 Central & South America Herpes Labialis Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Herpes Labialis Drugs by Country
10.1.1 Middle East and Africa Herpes Labialis Drugs Sales by Country
10.1.2 Middle East and Africa Herpes Labialis Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Herpes Labialis Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Herpes Labialis Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description and Business Overview
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Herpes Labialis Drugs Products Offered
11.1.5 GSK Related Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description and Business Overview
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Herpes Labialis Drugs Products Offered
11.2.5 Novartis Related Developments
11.3 Teva
11.3.1 Teva Corporation Information
11.3.2 Teva Description and Business Overview
11.3.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Teva Herpes Labialis Drugs Products Offered
11.3.5 Teva Related Developments
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Description and Business Overview
11.4.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Mylan Herpes Labialis Drugs Products Offered
11.4.5 Mylan Related Developments
11.5 Cadila
11.5.1 Cadila Corporation Information
11.5.2 Cadila Description and Business Overview
11.5.3 Cadila Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Cadila Herpes Labialis Drugs Products Offered
11.5.5 Cadila Related Developments
11.6 Apotex
11.6.1 Apotex Corporation Information
11.6.2 Apotex Description and Business Overview
11.6.3 Apotex Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Apotex Herpes Labialis Drugs Products Offered
11.6.5 Apotex Related Developments
11.7 Daewoong Pharmaceutical
11.7.1 Daewoong Pharmaceutical Corporation Information
11.7.2 Daewoong Pharmaceutical Description and Business Overview
11.7.3 Daewoong Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Daewoong Pharmaceutical Herpes Labialis Drugs Products Offered
11.7.5 Daewoong Pharmaceutical Related Developments
11.8 Livzon
11.8.1 Livzon Corporation Information
11.8.2 Livzon Description and Business Overview
11.8.3 Livzon Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Livzon Herpes Labialis Drugs Products Offered
11.8.5 Livzon Related Developments
11.9 Luoxin
11.9.1 Luoxin Corporation Information
11.9.2 Luoxin Description and Business Overview
11.9.3 Luoxin Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Luoxin Herpes Labialis Drugs Products Offered
11.9.5 Luoxin Related Developments
11.10 Med shine
11.10.1 Med shine Corporation Information
11.10.2 Med shine Description and Business Overview
11.10.3 Med shine Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Med shine Herpes Labialis Drugs Products Offered
11.10.5 Med shine Related Developments
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description and Business Overview
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Herpes Labialis Drugs Products Offered
11.1.5 GSK Related Developments
11.12 Blistex
11.12.1 Blistex Corporation Information
11.12.2 Blistex Description and Business Overview
11.12.3 Blistex Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Blistex Products Offered
11.12.5 Blistex Related Developments
11.13 Kelun Group
11.13.1 Kelun Group Corporation Information
11.13.2 Kelun Group Description and Business Overview
11.13.3 Kelun Group Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Kelun Group Products Offered
11.13.5 Kelun Group Related Developments
11.14 Hikma
11.14.1 Hikma Corporation Information
11.14.2 Hikma Description and Business Overview
11.14.3 Hikma Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Hikma Products Offered
11.14.5 Hikma Related Developments
11.15 Haiwang
11.15.1 Haiwang Corporation Information
11.15.2 Haiwang Description and Business Overview
11.15.3 Haiwang Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Haiwang Products Offered
11.15.5 Haiwang Related Developments
11.16 Carmex
11.16.1 Carmex Corporation Information
11.16.2 Carmex Description and Business Overview
11.16.3 Carmex Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Carmex Products Offered
11.16.5 Carmex Related Developments
11.17 Cipher
11.17.1 Cipher Corporation Information
11.17.2 Cipher Description and Business Overview
11.17.3 Cipher Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Cipher Products Offered
11.17.5 Cipher Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Herpes Labialis Drugs Market Estimates and Projections by Region
12.1.1 Global Herpes Labialis Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Herpes Labialis Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Herpes Labialis Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Herpes Labialis Drugs Sales Forecast (2021-2026)
12.2.2 North America: Herpes Labialis Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Herpes Labialis Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Herpes Labialis Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Herpes Labialis Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Herpes Labialis Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Herpes Labialis Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Herpes Labialis Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Herpes Labialis Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Herpes Labialis Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Herpes Labialis Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Herpes Labialis Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Herpes Labialis Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Herpes Labialis Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Herpes Labialis Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Herpes Labialis Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Herpes Labialis Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Herpes Labialis Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Herpes Labialis Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Herpes Labialis Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Herpes Labialis Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Herpes Labialis Drugs Market Segments
Table 2. Ranking of Global Top Herpes Labialis Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Herpes Labialis Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Valacyclovir
Table 5. Major Manufacturers of Aciclovir
Table 6. Major Manufacturers of Famciclovir
Table 7. Major Manufacturers of Docosanol
Table 8. Major Manufacturers of Other
Table 9. Global Herpes Labialis Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Herpes Labialis Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Herpes Labialis Drugs Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Herpes Labialis Drugs Sales Market Share by Regions (2015-2020)
Table 13. Global Herpes Labialis Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Herpes Labialis Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Herpes Labialis Drugs Sales Share by Manufacturers (2015-2020)
Table 16. Global Herpes Labialis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Herpes Labialis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Labialis Drugs as of 2019)
Table 18. Herpes Labialis Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Herpes Labialis Drugs Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Herpes Labialis Drugs Price (2015-2020) (USD/Pcs)
Table 21. Herpes Labialis Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Herpes Labialis Drugs Product Type
Table 23. Date of International Manufacturers Enter into Herpes Labialis Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Herpes Labialis Drugs Sales by Type (2015-2020) (K Pcs)
Table 26. Global Herpes Labialis Drugs Sales Share by Type (2015-2020)
Table 27. Global Herpes Labialis Drugs Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Herpes Labialis Drugs Revenue Share by Type (2015-2020)
Table 29. Herpes Labialis Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Herpes Labialis Drugs Sales by Application (2015-2020) (K Pcs)
Table 31. Global Herpes Labialis Drugs Sales Share by Application (2015-2020)
Table 32. North America Herpes Labialis Drugs Sales by Country (2015-2020) (K Pcs)
Table 33. North America Herpes Labialis Drugs Sales Market Share by Country (2015-2020)
Table 34. North America Herpes Labialis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Herpes Labialis Drugs Revenue Market Share by Country (2015-2020)
Table 36. North America Herpes Labialis Drugs Sales by Type (2015-2020) (K Pcs)
Table 37. North America Herpes Labialis Drugs Sales Market Share by Type (2015-2020)
Table 38. North America Herpes Labialis Drugs Sales by Application (2015-2020) (K Pcs)
Table 39. North America Herpes Labialis Drugs Sales Market Share by Application (2015-2020)
Table 40. Europe Herpes Labialis Drugs Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Herpes Labialis Drugs Sales Market Share by Country (2015-2020)
Table 42. Europe Herpes Labialis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Herpes Labialis Drugs Revenue Market Share by Country (2015-2020)
Table 44. Europe Herpes Labialis Drugs Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Herpes Labialis Drugs Sales Market Share by Type (2015-2020)
Table 46. Europe Herpes Labialis Drugs Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Herpes Labialis Drugs Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Herpes Labialis Drugs Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Herpes Labialis Drugs Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Herpes Labialis Drugs Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Herpes Labialis Drugs Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Herpes Labialis Drugs Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Herpes Labialis Drugs Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Herpes Labialis Drugs Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Herpes Labialis Drugs Sales Market Share by Application (2015-2020)
Table 56. Latin America Herpes Labialis Drugs Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Herpes Labialis Drugs Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Herpes Labialis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Herpes Labialis Drugs Revenue Market Share by Country (2015-2020)
Table 60. Latin America Herpes Labialis Drugs Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Herpes Labialis Drugs Sales Market Share by Type (2015-2020)
Table 62. Latin America Herpes Labialis Drugs Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Herpes Labialis Drugs Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Herpes Labialis Drugs Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Herpes Labialis Drugs Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Herpes Labialis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Herpes Labialis Drugs Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Herpes Labialis Drugs Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Herpes Labialis Drugs Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Herpes Labialis Drugs Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Herpes Labialis Drugs Sales Market Share by Application (2015-2020)
Table 72. GSK Corporation Information
Table 73. GSK Description and Major Businesses
Table 74. GSK Herpes Labialis Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. GSK Product
Table 76. GSK Recent Development
Table 77. Novartis Corporation Information
Table 78. Novartis Description and Major Businesses
Table 79. Novartis Herpes Labialis Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Novartis Product
Table 81. Novartis Recent Development
Table 82. Teva Corporation Information
Table 83. Teva Description and Major Businesses
Table 84. Teva Herpes Labialis Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Teva Product
Table 86. Teva Recent Development
Table 87. Mylan Corporation Information
Table 88. Mylan Description and Major Businesses
Table 89. Mylan Herpes Labialis Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Mylan Product
Table 91. Mylan Recent Development
Table 92. Cadila Corporation Information
Table 93. Cadila Description and Major Businesses
Table 94. Cadila Herpes Labialis Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Cadila Product
Table 96. Cadila Recent Development
Table 97. Apotex Corporation Information
Table 98. Apotex Description and Major Businesses
Table 99. Apotex Herpes Labialis Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Apotex Product
Table 101. Apotex Recent Development
Table 102. Daewoong Pharmaceutical Corporation Information
Table 103. Daewoong Pharmaceutical Description and Major Businesses
Table 104. Daewoong Pharmaceutical Herpes Labialis Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Daewoong Pharmaceutical Product
Table 106. Daewoong Pharmaceutical Recent Development
Table 107. Livzon Corporation Information
Table 108. Livzon Description and Major Businesses
Table 109. Livzon Herpes Labialis Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Livzon Product
Table 111. Livzon Recent Development
Table 112. Luoxin Corporation Information
Table 113. Luoxin Description and Major Businesses
Table 114. Luoxin Herpes Labialis Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Luoxin Product
Table 116. Luoxin Recent Development
Table 117. Med shine Corporation Information
Table 118. Med shine Description and Major Businesses
Table 119. Med shine Herpes Labialis Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Med shine Product
Table 121. Med shine Recent Development
Table 122. Bayer (Campho Phenique) Corporation Information
Table 123. Bayer (Campho Phenique) Description and Major Businesses
Table 124. Bayer (Campho Phenique) Herpes Labialis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Bayer (Campho Phenique) Product
Table 126. Bayer (Campho Phenique) Recent Development
Table 127. Blistex Corporation Information
Table 128. Blistex Description and Major Businesses
Table 129. Blistex Herpes Labialis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. Blistex Product
Table 131. Blistex Recent Development
Table 132. Kelun Group Corporation Information
Table 133. Kelun Group Description and Major Businesses
Table 134. Kelun Group Herpes Labialis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 135. Kelun Group Product
Table 136. Kelun Group Recent Development
Table 137. Hikma Corporation Information
Table 138. Hikma Description and Major Businesses
Table 139. Hikma Herpes Labialis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 140. Hikma Product
Table 141. Hikma Recent Development
Table 142. Haiwang Corporation Information
Table 143. Haiwang Description and Major Businesses
Table 144. Haiwang Herpes Labialis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 145. Haiwang Product
Table 146. Haiwang Recent Development
Table 147. Carmex Corporation Information
Table 148. Carmex Description and Major Businesses
Table 149. Carmex Herpes Labialis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 150. Carmex Product
Table 151. Carmex Recent Development
Table 152. Cipher Corporation Information
Table 153. Cipher Description and Major Businesses
Table 154. Cipher Herpes Labialis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 155. Cipher Product
Table 156. Cipher Recent Development
Table 157. Global Herpes Labialis Drugs Sales Forecast by Regions (2021-2026) (K Pcs)
Table 158. Global Herpes Labialis Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 159. Global Herpes Labialis Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 160. Global Herpes Labialis Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 161. North America: Herpes Labialis Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 162. North America: Herpes Labialis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 163. Europe: Herpes Labialis Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 164. Europe: Herpes Labialis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 165. Asia Pacific: Herpes Labialis Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 166. Asia Pacific: Herpes Labialis Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 167. Latin America: Herpes Labialis Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 168. Latin America: Herpes Labialis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 169. Middle East and Africa: Herpes Labialis Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 170. Middle East and Africa: Herpes Labialis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 171. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 172. Key Challenges
Table 173. Market Risks
Table 174. Main Points Interviewed from Key Herpes Labialis Drugs Players
Table 175. Herpes Labialis Drugs Customers List
Table 176. Herpes Labialis Drugs Distributors List
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Herpes Labialis Drugs Product Picture
Figure 2. Global Herpes Labialis Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Valacyclovir Product Picture
Figure 4. Aciclovir Product Picture
Figure 5. Famciclovir Product Picture
Figure 6. Docosanol Product Picture
Figure 7. Other Product Picture
Figure 8. Global Herpes Labialis Drugs Sales Market Share by Application in 2020 & 2026
Figure 9. External Use
Figure 10. Oral
Figure 11. Injection
Figure 12. Herpes Labialis Drugs Report Years Considered
Figure 13. Global Herpes Labialis Drugs Market Size 2015-2026 (US$ Million)
Figure 14. Global Herpes Labialis Drugs Sales 2015-2026 (K Pcs)
Figure 15. Global Herpes Labialis Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Herpes Labialis Drugs Sales Market Share by Region (2015-2020)
Figure 17. Global Herpes Labialis Drugs Sales Market Share by Region in 2019
Figure 18. Global Herpes Labialis Drugs Revenue Market Share by Region (2015-2020)
Figure 19. Global Herpes Labialis Drugs Revenue Market Share by Region in 2019
Figure 20. Global Herpes Labialis Drugs Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Herpes Labialis Drugs Revenue in 2019
Figure 22. Herpes Labialis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Herpes Labialis Drugs Sales Market Share by Type (2015-2020)
Figure 24. Global Herpes Labialis Drugs Sales Market Share by Type in 2019
Figure 25. Global Herpes Labialis Drugs Revenue Market Share by Type (2015-2020)
Figure 26. Global Herpes Labialis Drugs Revenue Market Share by Type in 2019
Figure 27. Global Herpes Labialis Drugs Market Share by Price Range (2015-2020)
Figure 28. Global Herpes Labialis Drugs Sales Market Share by Application (2015-2020)
Figure 29. Global Herpes Labialis Drugs Sales Market Share by Application in 2019
Figure 30. Global Herpes Labialis Drugs Revenue Market Share by Application (2015-2020)
Figure 31. Global Herpes Labialis Drugs Revenue Market Share by Application in 2019
Figure 32. North America Herpes Labialis Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Herpes Labialis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Herpes Labialis Drugs Sales Market Share by Country in 2019
Figure 35. North America Herpes Labialis Drugs Revenue Market Share by Country in 2019
Figure 36. U.S. Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Herpes Labialis Drugs Market Share by Type in 2019
Figure 41. North America Herpes Labialis Drugs Market Share by Application in 2019
Figure 42. Europe Herpes Labialis Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Herpes Labialis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Herpes Labialis Drugs Sales Market Share by Country in 2019
Figure 45. Europe Herpes Labialis Drugs Revenue Market Share by Country in 2019
Figure 46. Germany Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Herpes Labialis Drugs Market Share by Type in 2019
Figure 57. Europe Herpes Labialis Drugs Market Share by Application in 2019
Figure 58. Asia Pacific Herpes Labialis Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Herpes Labialis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Herpes Labialis Drugs Sales Market Share by Region in 2019
Figure 61. Asia Pacific Herpes Labialis Drugs Revenue Market Share by Region in 2019
Figure 62. China Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Herpes Labialis Drugs Market Share by Type in 2019
Figure 85. Asia Pacific Herpes Labialis Drugs Market Share by Application in 2019
Figure 86. Latin America Herpes Labialis Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Herpes Labialis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Herpes Labialis Drugs Sales Market Share by Country in 2019
Figure 89. Latin America Herpes Labialis Drugs Revenue Market Share by Country in 2019
Figure 90. Mexico Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Herpes Labialis Drugs Market Share by Type in 2019
Figure 97. Latin America Herpes Labialis Drugs Market Share by Application in 2019
Figure 98. Middle East and Africa Herpes Labialis Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Herpes Labialis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Herpes Labialis Drugs Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Herpes Labialis Drugs Revenue Market Share by Country in 2019
Figure 102. Turkey Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Herpes Labialis Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Herpes Labialis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Herpes Labialis Drugs Market Share by Type in 2019
Figure 109. Middle East and Africa Herpes Labialis Drugs Market Share by Application in 2019
Figure 110. North America Herpes Labialis Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Herpes Labialis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Herpes Labialis Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Herpes Labialis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Herpes Labialis Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Herpes Labialis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Herpes Labialis Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Herpes Labialis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Herpes Labialis Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Herpes Labialis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
口唇ヘルペス治療の世界市場（～2026年） Market Analysis and Insights: Global Herpes Labialis Treatment Market The global Herpes Labialis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Herpes Labialis Treatment Scope and Market Size Herpes Labialis…- 口唇ヘルペス治療・予防の世界市場（～2026年） Market Analysis and Insights: Global Treatment and Prevention of Herpes Labialis Market The global Treatment and Prevention of Herpes Labialis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Treatment and Prevention of…
- 帯状疱疹感染症治療の世界市場（～2026年） Herpes Zoster (shingles) is a cutaneous, acute viral infection caused by the varicella-zoster virus. Herpes Zoster is the outbreak of rash on the skin that cause burning and pain. Herpes Zoster is caused by the same virus which cause chickenpox. The virus may live in your nervous system for many yea…
- 性器ヘルペス治療の世界市場（～2026年） Market Analysis and Insights: Global Genital Herpes Treatment Market The global Genital Herpes Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Genital Herpes Treatment Scope and Market Size Genital Herpes Tre…
- ヘルペス治療の世界市場（～2026年） Genital herpes is a common sexually transmitted disease. With the increase in population of various regions, there is also an increase in the rate of health issues around the world. As the rate of diseases grow, the treatment markets are also expected to grow substantially. With respect to sexually …